Molecular genetic analysis of oligodendroglial tumors

被引:49
|
作者
Hartmann, C
Mueller, W
Lass, U
Kamel-Reid, S
von Deimling, A [1 ]
机构
[1] Humboldt Univ, Charite, Dept Neuropathol, Univ Med Berlin, D-13353 Berlin, Germany
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
1p; 19q; loss of heterozygosity; oligodendroglioma; oligoastrocytoma;
D O I
10.1093/jnen/64.1.10
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Deletions on the short arm of chromosome 1 (1p) and the long arm of chromosome 19 (19q) are molecular hallmark lesions of oligodendroglial tumors. Ever since oligodendroglial tumors with 1p and 19q deletions were shown to respond to chemotherapy, neuropathologists have been facing increasing requests for such molecular analysis. Therefore, there is increasing demand for reliable and simple assays. This brief report compiles information on different technical approaches, including manual and automated loss of heterozygosity analysis, fluorescence in situ hybridization techniques, and quantitative polymerase chain reaction. Herein we present a detailed protocol describing loss of heterozygosity analysis with microsatellite markers currently in use for two multicenter studies.
引用
收藏
页码:10 / 14
页数:5
相关论文
共 50 条
  • [41] Clinical and Molecular Analysis of Glioblastoma with Oligodendroglial Component
    Myung, J. K.
    Cho, H. J.
    Kim, H. N.
    Park, S-H
    LABORATORY INVESTIGATION, 2014, 94 : 439A - 439A
  • [42] Clinical and Molecular Analysis of Glioblastoma with Oligodendroglial Component
    Myung, J. K.
    Cho, H. J.
    Kim, H. N.
    Park, S-H
    MODERN PATHOLOGY, 2014, 27 : 439A - 439A
  • [43] Molecular genetic analysis of oligodendroglial tumors for allelic deletions on 1p and mutations of the CDKN2C gene at 1p32.
    Reifenberger, G
    Husemann, K
    Wolter, M
    Büschges, R
    Boström, J
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (05): : 513 - 513
  • [44] A subset of spontaneous canine oligodendroglial tumors share genetic similarities with human oligodendrogliomas
    Rynearson, Amanda
    Giannini, Caterina
    Rodriguez, Fausto
    Passe, Sandra
    Blanchard, Terrell
    McElwain, Terry
    Marler, Ronald
    Jenkins, Robert
    NEURO-ONCOLOGY, 2007, 9 (04) : 536 - 536
  • [45] Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors
    Kuo, Lu-Ting
    Kuo, Kuang-Ting
    Lee, Ming-Jang
    Wei, Chih-Chun
    Scaravilli, Francesco
    Tsai, Jui-Chang
    Tseng, Ham-Min
    Kuo, Meng-Fai
    Tu, Yong-Kwang
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (12) : 2872 - 2879
  • [46] Chemotherapy for the treatment of oligodendroglial tumors
    Chinot, O
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 13 - 18
  • [47] Gene expression in oligodendroglial tumors
    Shaw, Elisabeth J.
    Haylock, Brian
    Husband, David
    du Plessis, Daniel
    Sibson, D. Ross
    Warnke, Peter C.
    Walker, Carol
    CELLULAR ONCOLOGY, 2011, 34 (04) : 355 - 367
  • [48] Methylation Patterns of Oligodendroglial Tumors
    Melendez, B.
    Mur, P.
    Mollejo, M.
    Fiano, C.
    Garcia, J. F.
    Hernandez Lain, A.
    Rodriguez de Lope, A.
    Rey, J. A.
    LABORATORY INVESTIGATION, 2013, 93 : 436A - 437A
  • [49] Gene expression in oligodendroglial tumors
    Elisabeth J. Shaw
    Brian Haylock
    David Husband
    Daniel du Plessis
    D. Ross Sibson
    Peter C. Warnke
    Carol Walker
    Cellular Oncology, 2011, 34 : 355 - 367
  • [50] Gene expression in oligodendroglial tumors
    Shaw, Elisabeth J.
    Haylock, Brian
    Husband, David
    du Plessis, Daniel
    Sibson, D. Ross
    Warnke, Peter C.
    Walker, Carol
    ANALYTICAL CELLULAR PATHOLOGY, 2010, 33 (02) : 81 - 94